The FDA has approved Ozempic (semaglutide) to reduce the risk of kidney disease worsening and cardiovascular death in those with T2D and CKD.
Climate change is increasing the risk of urological diseases, including cancer and kidney conditions, while urological ...
Many older people develop chronic kidney disease and are also likely to be on cholesterol-lowering drugs known as statins.